Hugh Rosen

Hugh Rosen

Director/Board Member bij REGULUS THERAPEUTICS INC.

Vermogen: 5 100 $ op 31-03-2024

64 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Hugh Rosen is the founder of Receptos LLC, which was founded in 2008.
He is currently the Chairman & President of ActivX Biosciences, Inc. since 2017 and an Independent Director of Regulus Therapeutics, Inc. since 2016.
Dr. Rosen was a Director of the Association of American Physicians and an Executive Director-Immunology & Rheumatology at Merck Research Laboratories Massachusetts LLC.
He was also a Scientific Director at Scleroderma Foundation from 1992 to 2000 and a Professor at The Scripps Research Institute from 2002 to 2017.
Dr. Rosen holds a doctorate degree from the University of Oxford and the University of Cape Town.
Dr. Rosen is also the founder of BlackThorn Therapeutics, Inc.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
10-08-2023 1 771 ( 0.00% ) 5 100 $ 31-03-2024

Actieve functies van Hugh Rosen

BedrijvenFunctieBegin
REGULUS THERAPEUTICS INC. Director/Board Member 02-06-2016
Chairman 01-04-2017
Alle actieve functies van Hugh Rosen

Eerdere bekende functies van Hugh Rosen

BedrijvenFunctieEinde
Corporate Officer/Principal 01-03-2017
Scleroderma Foundation Chief Tech/Sci/R&D Officer 01-01-2000
Founder -
Director/Board Member -
Corporate Officer/Principal -
Ervaring van Hugh Rosen in detail bekijken

Opleiding van Hugh Rosen

University of Oxford Doctorate Degree
University of Cape Town Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hugh Rosen in detail bekijken

Connecties

60

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
REGULUS THERAPEUTICS INC.

Health Technology

Bedrijven in privébezit6

Health Technology

Health Technology

Health Technology

Scleroderma Foundation

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Hugh Rosen